Companies

OpGen to Raise $3.4M in Direct Stock Offering

BARDA Provides Additional $3.7M to T2 Biosystems Under Contract Option

OraSure Technologies Awarded $8.6M BARDA Contract for Next-Gen Ebola Test

Thermo Fisher Gets FDA OK for CDx Test to Guide Use of Lilly Drug in Lung, Thyroid Cancers

Ravgen Wins $273M Award in Patent Infringement Suit Against Labcorp

UK's NICE to Accelerate Assessment of Genedrive Test

Bio-Techne Files UK Patent Infringement Suit Against Molecular Instruments

Bionano Genomics Launches CLIA-Certified Laboratory, First OGM-Based Test

Caris Life Sciences to Offer Molecular Profiling Services on Flatiron Health Platform

PerkinElmer's Oxford Immunotec Gains FDA Go-Ahead for TB Test Automation

Sophia Genetics Partners With MSK on Clinical Decision Support, Boundless Bio on ecDNA Detection

BioMérieux, BrightInsight Partner for Clinical Decision Support Solution

Roche Obtains CE Mark for Three Tests on New Cobas PCR Instrument

Foundation Medicine, Day One Biopharmaceuticals to Develop CDx for Tovorafenib

OraSure Technologies HIV Self-Test Selected for CDC Program

FIND, Curetis Ink R&D Collaboration Agreement

Roche Gets FDA 510(k) Clearance for New Cobas Instrument

Epigenomics Expecting Lower Loss in 2022 as It Launches Liquid Biopsy Study